CEREVEL THERAPEUTICS HLDNG I's ticker is CEREW and the CUSIP is 15678U102. A total of 38 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $4,307,000 | – | 283,332 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 72,466 | $409,000 | 0.22% |
| Altium Capital Management LP | 64,666 | $365,000 | 0.14% |
| Nantahala Capital Management | 283,332 | $4,307,000 | 0.13% |
| Governors Lane LP | 196,034 | $1,108,000 | 0.09% |
| SPHERA FUNDS MANAGEMENT LTD. | 166,332 | $940,000 | 0.08% |
| Monashee Investment Management LLC | 99,998 | $565,000 | 0.08% |
| Context Capital Management, LLC | 85,967 | $486,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 75,400 | $1,250,000 | 0.05% |
| Maven Securities LTD | 56,667 | $338,000 | 0.03% |
| Walleye Capital LLC | 70,649 | $399,000 | 0.03% |